Tag: Limited-Stage Small Cell Lung Cancer

Home / Limited-Stage Small Cell Lung Cancer

Categories

Durvalumab is approved by the USFDA for limited-stage small cell lung cancer

 On December 4, 2024, the Food and Drug Administration sanctioned durvalumab (Imfinzi, AstraZeneca) for adults with limited-stage small cell lung cancer (LS-SCLC) whose condition remains stable after...
limited-stage-small-cell-lung-cancer

Scan the code